ASCL1 and metastatic malignant neoplasm in the lymph nodes: ASCL1 were highly expressed in 42.5% (105/247) of pure SCLC patients, and a significant difference was found in variables including TNM staging, lymph node metastasis, nerve invasion, as well as OS.